Bilateral sub-deltoid bursitis in a patient receiving infliximab for Crohn's disease.

@article{Bellakhal2019BilateralSB,
  title={Bilateral sub-deltoid bursitis in a patient receiving infliximab for Crohn's disease.},
  author={Syrine Bellakhal and Maissa Abbes and Mohamed Taieb Jomni and Imen Abdelaali and Mehdi Charfi and Mohamed Hedi Douggui},
  journal={Current drug safety},
  year={2019}
}
PURPOSE We report here a case of inflammatory bursitis in a patient with crohn's disease after switching to biosimilar infliximab. METHODS The patient's clinical, biological and imaging data were reviewed as well as the literature on inflammatory bursitis in patients under infliximab therapy. RESULTS A 41-year-old man with crohn's disease evolving from 3 years was referred to infliximab therapy at a dose of 5mg/kg because of an aggressive resistant perineal fistula. After 14 infusions of… CONTINUE READING

Topics from this paper.